If you’re seeking insights into Focal Nodular Hyperplasia and its evaluation in Long Island, NY, you’ve landed in the right place. Our gastroenterology practice is led by Dr. Mit Shah, MD, a board-certified gastroenterologist with extensive training in liver disorders. We are dedicated to understanding benign liver tumors and providing comprehensive assessments tailored to your needs. With advanced techniques and a patient-centered approach, we ensure that you receive the best support for your liver health.
I had a pleasant experience at this office. Dr. Shah was very professional, kind and knowledgeable. The office is very clean and welcoming. The staff is friendly and make you feel relaxed. Very easy to schedule procedures and the wait time is very short. I highly recommend them.
What Is Focal Nodular Hyperplasia
Focal Nodular Hyperplasia (FNH) is a benign liver tumor that ranks as the second most common type of benign liver lesion, accounting for approximately 8% of all primary liver lesions. Primarily occurring in young women, FNH is generally asymptomatic and often goes unnoticed. Although the presence of a liver tumor may evoke concerns, it’s important to emphasize that FNH is considered non-cancerous and commonly arises within a normal liver background.
Signs of Benign Liver Tumors You Should Know
Many individuals with benign liver tumors, including FNH, typically do not experience noticeable symptoms. However, some signs that may warrant an evaluation include:
- Unexplained abdominal pain
- Feeling of fullness after meals
- Swelling in the abdomen
It’s crucial for residents in Long Island, Queens, and Levittown to monitor their liver health, especially if any of these symptoms arise. Early consultation with our practice can lead to timely evaluations and peace of mind.

How MRI Plays a Role in Diagnosis
Magnetic Resonance Imaging (MRI) is a key diagnostic tool in evaluating FNH. This imaging technique provides detailed images of the liver, enabling us to differentiate benign lesions from potentially malignant growths. By utilizing MRI, we can accurately assess the nature of the liver lesion and confirm its benign status, alleviating any fears surrounding diagnosis.
Monitoring Your Liver Health Over Time
For individuals diagnosed with FNH, regular monitoring is essential. Many benign liver tumors, including FNH, tend to remain stable in size and do not necessitate treatment. Our practice, led by experienced physicians with annual volumes of >1000 diagnostic cases, recommends routine scans and health consultations to ensure your liver health is optimally managed over time. This proactive approach can significantly ease concerns about liver health and increase confidence in your well-being.
Demographics of Focal Nodular Hyperplasia Patients
Focal Nodular Hyperplasia is most commonly diagnosed in young women, with a prevalence in the general U.S. population estimated between 0.6% and 3%. This highlights the importance of liver health awareness among this demographic. Understanding the prevalence and characteristics of FNH is crucial for early detection and management. Our practice is committed to educating patients in Long Island and surrounding areas about the importance of routine evaluations and consultations regarding liver health.
Frequently Asked Questions About Focal Nodular Hyperplasia
-
If you suspect you have FNH, it’s important to schedule an evaluation with a gastroenterologist. Early assessment can help confirm the diagnosis and guide monitoring.
-
Most cases of FNH do not require treatment, as they are benign and often asymptomatic. Monitoring is typically sufficient.
-
Your physician will recommend a personalized monitoring plan, often involving regular imaging studies to track any changes in the lesion.
-
Generally, patients with FNH do not need specific dietary restrictions. However, maintaining a healthy lifestyle is important for overall liver health.
-
While the exact cause of FNH remains unclear, it is more frequently diagnosed in women, particularly those of childbearing age.

Why Choose Our Gastroenterology Practice for Evaluations
Our gastroenterology practice stands out in Long Island, NY for its comprehensive care and specialized focus on liver disorders. Led by Dr. Mit Shah, MD, and Dr. Davinder Singh, MD—both board-certified in Internal Medicine and Gastroenterology—our team is equipped with extensive training and experience in gastroenterology. With affiliations to prominent medical associations, including the American Gastroenterological Association (AGA) and the American College of Gastroenterology (ACG), we are committed to delivering high-quality evaluations for patients with FNH and other liver-related concerns. We utilize state-of-the-art diagnostic technologies, ensuring accurate and timely assessments—serving residents of Queens, Levittown, and nearby communities with unparalleled care.
About UsSchedule Your Consultation Today
Ensure your liver health is prioritized by scheduling an appointment with our gastroenterology practice in Long Island, NY. Our team is dedicated to providing thorough evaluations for Focal Nodular Hyperplasia and other liver disorders. Take the first step towards informed health management and confidence in your liver wellness.